Table 2.
Treatments | Cultures of tissues | |||
---|---|---|---|---|
BSK-H^ | mBSK-II^ | Combined Cultures^ | p value | |
Infected Untreated (OG) | 3/3 | ND | 3/3 | |
Infected Untreated (IP) | 5/5 | ND | 5/5 | |
Infected Untreated (SC) | 2/2 | ND | 2/2 | |
Azlocillin (IP) | 4/5 | ND | 4/5 | 1b |
Bactrim (OG) | 5/5 | ND | 5/5 | 1a |
Disulfiram (OG) | 5/5 | ND | 5/5 | 1a |
Carbomycin (SC) | 5/5 | 5/5 | 5/5 | 1c |
Dapsone (OG) | 3/5 | 3/5 | 3/5 | 0.4643a |
Rifampicin (OG) | 3/5 | 3/5 | 3/5 | 0.4643a |
Cefotaxime (IP) | 1/5 | 1/5 | 1/5 | 0.0476 b* |
Loratadine (OG) | 3/5 | 3/5 | 3/5 | 0.4643a |
ND, not done; OG, oral gavage; IP, intraperitoneal; SC, subcutaneous. Combined cultures compared to a = OG control group, b = IP control group, c = SC control group. ^ Number of mice positive for at least one tissue/total number of mice tested. * Statistically significant. Fisher exact test, the result is significant at p < 0.05.